267 results
Keyword Fluoxetine Remove keyword
-
List item
Veterinary medicine European public assessment report (EPAR): Reconcile
fluoxetine, Dogs
Date of authorisation: 08/07/2008, Revision: 14, Authorised, Last updated: 16/06/2021Authorised fluoxetine Overview This is a summary … contains the active substance fluoxetine. How is Reconcile used? Reconcile … How does Reconcile work? Fluoxetine is an antidepressant … -
List item
Referral: Fluoxetin NM
fluoxetine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/12/1997, EC decision date: 09/06/1998, Last updated: 19/06/1998Fluoxetin NM … Competent Authorities for Fluoxetin NM, capsules 20 mg. The Mutual … Marketing Authorisation for Fluoxetin NM with amendments to the … -
List item
Referral: Prozac
fluoxetine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/09/2002, Last updated: 18/06/2003Commission final decision Overview Fluoxetine is a Selective Serotonin … the benefit/risk ratio of fluoxetine is considered to be favourable … Non-Proprietary Name (INN): fluoxetine: Background inform... PDF … -
List item
Referral: Prozac
fluoxetine, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 01/06/2006, EC decision date: 21/08/2006, Last updated: 05/09/2006arbitration review of Prozac (fluoxetine) and associated names 1 … arbitration review of Prozac (fluoxetine) and associated names1, and … Non-Proprietary Name (INN): Fluoxetine BACKGROUND INFORMATION … -
List item
Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
atomoxetine, citalopram, escitalopram, fluoxetine, fluvoxamine, mianserine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 19/08/2005, Last updated: 03/11/2005duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … duloxetine 1 , escitalopram, fluoxetine,fluvoxamine, mianserine, milnacipran … -
List item
Press release: European Medicines Agency adopts a positive opinion for the use of Prozac in the treatment of children and adolescents suffering from depression
CHMP, Last updated: 06/06/2006the indication for Prozac (fluoxetine) and associated names to … SSRI) medicines, including fluoxetine, regarding the increased risk … the indication for Prozac (fluoxetine) and associated names to … -
List item
Human medicine European public assessment report (EPAR): Valdoxan
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009, Revision: 23, Authorised, Last updated: 25/11/2021other antidepressants, either fluoxetine or paroxetine, as an ‘active … placebo. However, no effect of fluoxetine or paroxetine was seen in … other antidepressants, either fluoxetine or paroxetine, as an ‘active … -
List item
Human medicine European public assessment report (EPAR): Thymanax
Agomelatine, Depressive Disorder, Major
Date of authorisation: 19/02/2009,
Date of refusal: 18/11/2006, Revision: 23, Authorised, Last updated: 24/11/2021other antidepressants, either fluoxetine or paroxetine, as an ‘active … placebo. However, no effect of fluoxetine or paroxetine was seen in … other antidepressants, either fluoxetine or paroxetine, as an ‘active … -
List item
News: European Medicines Agency finalises review of antidepressants in childrenand adolescents
CHMP, Last updated: 25/04/2005duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … duloxetine, escitalopram, fluoxetine, fluvoxamine, mianserine … -
List item
National expert: Angela Pollicino, Italian Medicines Agency (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 18.77 KB | PDF
effect of fluvoxamine or fluoxetine on plasma concetrations of … Carbamazepine coadministrations with fluoxetine or fluvoxamine. Ther Drug … interaction between fluvoxamine or fluoxetine on plasma concentrations … -
List item
National expert: Ines Ronnefahrt, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 79.79 KB | PDF
- Curriculum Vitae - 18.33 KB | PDF
Serotonin Re-uptake Inhibitor Fluoxetine: Case Study Using the European … -
List item
National expert: Ekaterini Tiligada, National Organization for Medicines (updated)
- Declaration of interests - 80.07 KB | PDF
- Curriculum Vitae - 38.9 KB | PDF
-
List item
National expert: Giacomo Capone, Italian Medicines Agency (updated)
- Declaration of interests - 79.77 KB | PDF
- Curriculum Vitae - 20.86 KB | PDF
antidepressant-like effect of fluoxetine in an animal model of depression" … antidepressant effect of fluoxetine in a rat model of depression"Brunello … -
List item
National expert: Emilio Perucca, Italian Medicines Agency (updated)
- Declaration of interests - 86.11 KB | PDF
- Curriculum Vitae - 109.64 KB | PDF
-
List item
National expert: Anette Solli Karlsen, Norwegian Medicines Agency (updated)
- Declaration of interests - 79.82 KB | PDF
- Curriculum Vitae - 23.3 KB | PDF
quot;Simultaneous determination of citalopram, fluoxetine, paroxetine and thier metabolites … -
List item
Human medicine European public assessment report (EPAR): Ganfort (updated)
bimatoprost, timolol, Glaucoma, Open-Angle; Ocular Hypertension
Date of authorisation: 19/05/2006, Revision: 22, Authorised, Last updated: 23/06/2022 -
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka
efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018,
, Revision: 8, Authorised, Last updated: 24/05/2022
-
List item
Human medicine European public assessment report (EPAR): Duloxetine Zentiva
duloxetine, Neuralgia; Depressive Disorder, Major; Anxiety Disorders; Diabetes Mellitus
Date of authorisation: 20/08/2015,, Revision: 10, Authorised, Last updated: 19/05/2022
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva
efavirenz, emtricitabine, tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 17/07/2017,, Revision: 8, Authorised, Last updated: 18/05/2022
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord (updated)
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 14, Authorised, Last updated: 13/06/2022
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Zentiva (previously Clopidogrel Winthrop) (updated)
clopidogrel, Stroke; Peripheral Vascular Diseases; Myocardial Infarction; Acute Coronary Syndrome
Date of authorisation: 15/07/2008, Revision: 31, Authorised, Last updated: 23/06/2022 -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm (updated)
clopidogrel (as hydrogen sulfate), Myocardial Infarction; Acute Coronary Syndrome; Peripheral Vascular Diseases; Stroke
Date of authorisation: 18/02/2015,, Revision: 13, Authorised, Last updated: 07/06/2022
-
List item
Human medicine European public assessment report (EPAR): Duloxetine Mylan
duloxetine, Neuralgia; Diabetic Neuropathies; Depressive Disorder, Major; Anxiety Disorders
Date of authorisation: 19/06/2015,, Revision: 17, Authorised, Last updated: 25/04/2022
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen)
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 30/06/2015,, Revision: 13, Authorised, Last updated: 12/05/2022
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)
clopidogrel (as hydrogen sulfate), Acute Coronary Syndrome; Peripheral Vascular Diseases; Myocardial Infarction; Stroke
Date of authorisation: 27/07/2009,, Revision: 18, Authorised, Last updated: 10/06/2022